Results 231 to 240 of about 156,340 (338)

Safety and Efficacy of Lucitanib Plus Toripalimab in Advanced Solid Tumors Refractory to Standard Therapies: An Open‐Label, Multicenter, Phase II Study

open access: yesMedComm, Volume 7, Issue 3, March 2026.
Lucitanib plus toripalimab showed manageable safety and encouraging antitumor activity in advanced solid tumors, particularly in PD‐1‐refractory nasopharyngeal carcinoma and recurrent endometrial carcinoma. Clinical responses were observed across subgroups regardless of prior immunotherapy.
Ting Zhou   +24 more
wiley   +1 more source

Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2015
Essi Ryödi   +6 more
semanticscholar   +1 more source

Weekly Subcutaneous VK2735, a GIP/GLP‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study

open access: yesObesity, Volume 34, Issue 3, Page 537-549, March 2026.
Four doses of VK2735 and a placebo group were included in the VENTURE study. Adults who were overweight or had obesity had significant weight loss when taking any dose of VK2735 for 13 weeks. More people lost at least 10% of their body weight as the dose increased.
Harold E. Bays   +9 more
wiley   +1 more source

Beyond the Norm: Atypical Manifestations of Aspergillosis

open access: yesRespirology Case Reports, Volume 14, Issue 3, March 2026.
We describe a rare case of Aspergillus infection presenting as a chest mass, underscoring the diagnostic challenges of fungal diseases in immunocompromised patients and highlighting the importance of considering unusual manifestations in clinical practice.
Leila Zahiri   +5 more
wiley   +1 more source

Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus: systematic review and meta‐analysis of clinical outcomes from non‐randomized studies

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 3, Page 272-282, March 2026.
ABSTRACT Objective Complete hydatidiform mole and coexisting normal fetus (CHMCF) is a rare condition for which there is significant heterogeneity in diagnosis, counseling and management of complications. The objective of this study was to summarize the prevalence of clinical outcomes in reported cases of CHMCF.
N. Salmeri   +8 more
wiley   +1 more source

The Impact of Feeding Organic Trace Minerals Using Advanced Chelate Technology on Reproductive Efficiency and Blood Parameters in Ghezel Ewes

open access: yesVeterinary Medicine and Science, Volume 12, Issue 2, March 2026.
Supplementing the flushing diet with organic trace minerals based on advanced chelate technology enhanced the reproductive performance of ewes as compared with inorganic trace minerals. ABSTRACT Background The bioavailability of trace minerals (TM) in a diet is important for improving reproductive performance and fertility parameters.
Sedigheh Vatankhah   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy